Software for dosage individualization of voriconazole for immunocompromised patients

William W. Hope, Michael Van Guilder, J. Peter Donnelly, Nicole M.A. Blijlevens, Roger J.M. Brüggemann, Roger W. Jelliffe, Michael N. Neely

Onderzoeksoutput: Bijdrage aan tijdschriftArtikelpeer review

40 Citaten (Scopus)


The efficacy of voriconazole is potentially compromised by considerable pharmacokinetic variability. There are increasing insights into voriconazole concentrations that are safe and effective for treatment of invasive fungal infections. Therapeutic drug monitoring is increasingly advocated. Software to aid in the individualization of dosing would be an extremely useful clinical tool. We developed software to enable the individualization of voriconazole dosing to attain predefined serum concentration targets. The process of individualized voriconazole therapy was based on concepts of Bayesian stochastic adaptive control. Multiple-model dosage design with feedback control was used to calculate dosages that achieved desired concentration targets with maximum precision. The performance of the software program was assessed using the data from 10 recipients of an allogeneic hematopoietic stem cell transplant (HSCT) receiving intravenous (i.v.) voriconazole. The program was able to model the plasma concentrations with a high level of precision, despite the wide range of concentration trajectories and interindividual pharmacokinetic variability. The voriconazole concentrations predicted after the last dosages were largely concordant with those actually measured. Simulations provided an illustration of the way in which the software can be used to adjust dosages of patients falling outside desired concentration targets. This software appears to be an extremely useful tool to further optimize voriconazole therapy and aid in therapeutic drug monitoring. Further prospective studies are now required to define the utility of the controller in daily clinical practice.

Originele taal-2Engels
Pagina's (van-tot)1888-1894
Aantal pagina's7
TijdschriftAntimicrobial Agents and Chemotherapy
Nummer van het tijdschrift4
StatusGepubliceerd - apr. 2013
Extern gepubliceerdJa


Duik in de onderzoeksthema's van 'Software for dosage individualization of voriconazole for immunocompromised patients'. Samen vormen ze een unieke vingerafdruk.

Citeer dit